Brief: Basilea's Partner Asahi Kasei Files For Isavuconazole Authorization In Japan

Basilea Pharmaceutica AG, Allschwil

26/07/2021 06:20

July 26 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * BASILEA’S PARTNER ASAHI KASEI PHARMA PREPARES NDA FILING
FOR THE
MARKETING AUTHORIZATION OF ISAVUCONAZOLE IN JAPAN BASED ON
POSITIVE PHASE 3 STUDY RESULTS

Source text for Eikon:  ID:nGNE8P1sbH 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 6600;))